Literature DB >> 19491007

Development of injection moulded matrix tablets based on mixtures of ethylcellulose and low-substituted hydroxypropylcellulose.

Thomas Quinten1, Yves Gonnissen, Els Adriaens, Thomas De Beer, Veerle Cnudde, Bert Masschaele, Luc Van Hoorebeke, Juergen Siepmann, Jean Paul Remon, Chris Vervaet.   

Abstract

The objective of this study was to produce sustained-release matrix tablets by means of injection moulding and to evaluate the influence of matrix composition, process temperature and viscosity grade of ethylcellulose on processability and drug release by means of a statistical design. The matrix tablets were physico-chemically characterized and the drug release mechanism and kinetics were studied. Formulations containing metoprolol tartrate (30%, model drug), ethylcellulose with dibutylsebacate (matrix former and plasticizer) and L-HPC were extruded and subsequently injection moulded into tablets (375mg, 10mm diameter, convex-shaped) at different temperatures (110, 120 and 130 degrees C). Dissolution tests were performed and tablets were characterized by means of DSC, X-ray powder diffraction studies, X-ray tomography, porosity and hardness. Tablets containing 30% metoprolol and 70% ethylcellulose (EC 4cps) showed an incomplete drug release within 24h (<50%). Formulations containing L-HPC and EC in a ratio of 20/50 and 27.5/42.5 resulted in nearly zero-order drug release, while the drug release rate was not constant when 35% L-HPC was included. Processing of these formulations was possible at all temperatures, but at higher processing temperatures the drug release rate decreased and tablet hardness increased. Higher viscosity grades of EC resulted in a faster drug release and a higher tablet hardness. The statistical design confirmed a significant influence of the EC and L-HPC concentration on drug release, while the processing temperature and EC viscosity grade did not affect drug release. Tablet porosity was low (<5%), independent of the formulation and process conditions. DSC and XRD demonstrated the formation of a solid dispersion. The hydration front in the tablets during dissolution was visualized by dynamic X-ray tomography, this technique also revealed an anisotropic pore structure through the tablet.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19491007     DOI: 10.1016/j.ejps.2009.02.006

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  12 in total

1.  A novel injection-molded capsular device for oral pulsatile delivery based on swellable/erodible polymers.

Authors:  Andrea Gazzaniga; Matteo Cerea; Alberto Cozzi; Anastasia Foppoli; Alessandra Maroni; Lucia Zema
Journal:  AAPS PharmSciTech       Date:  2011-01-26       Impact factor: 3.246

2.  Bilayer matrix tablets for prolonged actions of metformin hydrochloride and repaglinide.

Authors:  Wei He; Shijing Huang; Chunyan Zhou; Lin Cao; Jing Yao; Jianping Zhou; Guangji Wang; Lifang Yin
Journal:  AAPS PharmSciTech       Date:  2014-10-16       Impact factor: 3.246

3.  PVP VA64 as a novel release-modifier for sustained-release mini-matrices prepared via hot melt extrusion.

Authors:  Yongcheng Li; Ming Lu; Chuanbin Wu
Journal:  Drug Deliv Transl Res       Date:  2018-12       Impact factor: 4.617

Review 4.  Twin-screw extrusion of sustained-release oral dosage forms and medical implants.

Authors:  Xin Feng; Feng Zhang
Journal:  Drug Deliv Transl Res       Date:  2018-12       Impact factor: 4.617

5.  Manufacturing strategies to develop amorphous solid dispersions: An overview.

Authors:  Nicole Mendonsa; Bjad Almutairy; Venkata Raman Kallakunta; Sandeep Sarabu; Priyanka Thipsay; Suresh Bandari; Michael A Repka
Journal:  J Drug Deliv Sci Technol       Date:  2019-12-11       Impact factor: 3.981

6.  Preparation and evaluation of sustained-release matrix tablets based on metoprolol and an acrylic carrier using injection moulding.

Authors:  T Quinten; G P Andrews; T De Beer; L Saerens; W Bouquet; D S Jones; P Hornsby; J P Remon; C Vervaet
Journal:  AAPS PharmSciTech       Date:  2012-09-11       Impact factor: 3.246

7.  Risedronate-Loaded Macroporous Gel Foam Enriched with Nanohydroxyapatite: Preparation, Characterization, and Osteogenic Activity Evaluation Using Saos-2 Cells.

Authors:  Nadia M Morsi; Rehab Nabil Shamma; Nouran Osama Eladawy; Abdelfattah A Abdelkhalek
Journal:  AAPS PharmSciTech       Date:  2019-02-08       Impact factor: 4.026

8.  Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia.

Authors:  Rehab Nabil Shamma; Mona Hassan Aburahma
Journal:  Int J Nanomedicine       Date:  2014-11-26

9.  Continuous melt granulation to develop high drug loaded sustained release tablet of Metformin HCl.

Authors:  Pradnya Vaingankar; Purnima Amin
Journal:  Asian J Pharm Sci       Date:  2016-08-31       Impact factor: 6.598

10.  Single and dual drug release patterns from shellac wax-lutrol matrix tablets fabricated with fusion and molding techniques.

Authors:  T Phaechamud; C Choncheewa
Journal:  Indian J Pharm Sci       Date:  2015 Jan-Feb       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.